Efficacy and Tolerability of Fixed-Dose Combination of Perindopril/Indapamide in Type 2 Diabetes Mellitus: PICASSO Trial

Author： Farsang Csaba

Publisher： Springer Publishing Company

ISSN： 0741-238X

Source： Advances in Therapy, Vol.31, Iss.3, 2014-03, pp. : 333-344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study

By Holzgreve Heinrich Risler Teut Trenkwalder Peter

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1849-1858

Informa Healthcare

Access to resources Recommend Favorite

Fixed-dose combination rosiglitazone/glimepiride in the treatment of Type 2 diabetes mellitus

By Derosa Giuseppe Salvadeo Sibilla AT Cicero Arrigo FG

Therapy, Vol. 3, Iss. 5, 2006-09 ,pp. : 559-569

Future Medicine

Access to resources Recommend Favorite

Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients

By Mourad J. J. Le Jeune S.

Current Medical Research and Opinion, Vol. 25, Iss. 9, 2009-09 ,pp. : 2271-2280

Informa Healthcare

Access to resources Recommend Favorite

A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes

By Hutchins Valerie Zhang Bin Fleurence Rachael L. Krishnarajah Girishanthy Graham John

Current Medical Research and Opinion, Vol. 27, Iss. 6, 2011-06 ,pp. : 1157-1168

Informa Healthcare

Access to resources Recommend Favorite

Clinical experience with a low-dose fixed combination of perindopril plus indapamide in a primary-care setting: the PRETEND study

By Barrios Vivencio Escobar Carlos Divison Juan Antonio Medialdea Francisco

Therapy, Vol. 4, Iss. 5, 2007-09 ,pp. : 677-683

Future Medicine

Access to resources Recommend Favorite